Sign in
SCHEDULE 13G/A

Statement of Beneficial Ownership

Grace Therapeutics, Inc. Filed Acc 0001104659-26-128739

Stakes reported in this filing

Reporting person Shares Of the class
ADAR1 Capital Management, LLC 2,281,877 9.9%
Daniel Schneeberger 2,281,877 9.9%
ADAR1 Capital Management GP, LLC 1,940,042 8.6%

Members of a group can each report the same shares, so these rows overlap and don't add up.

Loading xslSCHEDULE_13G_X02/primary_doc.xml…